Project Grant R21DA064954
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, operating as RBHS-School of Nursing, $1,265,388 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to examine how product features in cannabis vape product marketing influence young adult use behaviors and risk perceptions. The project conducts a large-scale content analysis to identify and categorize product features conveyed in advertisements of leading cannabis vape...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $2,107,844 on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal mixed-methods study of nicotine pouch adoption and use patterns among U.S. adults. The research combines a nationally representative longitudinal survey with qualitative interviews to examine who uses nicotine pouches, reasons for adoption,...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $1.413 million on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop, refine, and test a telehealth-delivered motivational interviewing intervention for young adults who use electronic nicotine delivery systems (ENDS). The project will develop and test a cessation-induction intervention designed to prompt quit attempts in...
- The National Institute on Drug Abuse awarded Rutgers, The State University of New Jersey (RBHS-School of Nursing) $515,211 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on post-overdose treatment gaps and prevention opportunities in high-risk youth. The research examines nonfatal drug overdoses in adolescents and young adults to identify barriers to behavioral health treatment connection and to generate evidence for tailored prevention...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $1,411,502 on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test evidence-based communication messages aimed at preventing escalation in e-cigarette use frequency among youth who currently use e-cigarettes infrequently. The project will employ a multi-tiered approach to design targeted prevention messages for...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, School of Nursing, $722,948 on September 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized controlled trial examining the effects of tailored education about low-nicotine cigarettes on adult smokers' beliefs and behaviors. The research addresses a public health gap: U.S. adults conflate the addictive properties of nicotine with the health harms of tobacco...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey $139,612 on February 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support research integrating artificial intelligence and co-production methods to analyze communications in online substance use disorder recovery groups. Dr. Xiangyu Tao, a postdoctoral associate at the Rutgers Addiction Research Center, will conduct research examining how engagement in online peer support...
- The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey (doing business as RBHS-School of Nursing) $642,253 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct high-precision mapping of sex hormone modulation of reward value computations in opioid addiction. The research addresses disparities in medications for opioid use disorder treatment, which fails in a sizable proportion of patients, particularly female patients...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $631,094 on August 1, 2026, for research evaluating the neurocognitive, psychomimetic, and abuse-related effects of emerging psychoactive cannabinoids under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a five-year project (August 1, 2026 through June 30, 2031) examining vaporized delta-8 tetrahydrocannabinol (D8-THC) and hexahydrocannabinol (HHC)—novel cannabinoids marketed as legal...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $431,750 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded July 1, 2025, with completion targeted for June 30, 2027. This research project will conduct a multi-method investigation into premium cigar use patterns and marketing exposure to address significant gaps in evidence regarding public health impacts. The...
The National Institute on Drug Abuse awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $431,750 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to examine the youth appeal of hemp-derived intoxicating cannabis product marketing on social media. The award funds research into how delta-8 THC, THC-A, THC-P, and related products are marketed to youth on Instagram, TikTok, and YouTube. The project will systematically analyze marketing tactics employed by leading brands—including use of vibrant colors, dessert and fruit imagery, cartoon and anime characters, and pop culture references—and assess their behavioral influence on youth. The research addresses a gap in evidence: while these unregulated products have achieved substantial youth adoption since the 2018 Farm Bill and pose documented health risks including intoxication-related accidents, mental health concerns, and cannabis dependence, the marketing practices driving youth interest remain largely unexamined. Work is performed in Newark, New Jersey, with a period of performance from August 1, 2026, through July 31, 2028. This is a Project Grant, a form of assistance funding under NIDA's substance use research portfolio supporting basic, clinical, translational, and implementation research in prevention, diagnosis, and treatment of drug use and addiction.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $431.8k | 7/29/26 |